Abstract Details

Title A population-based approach to chemotherapy-induced peripheral neuropathy reveals the disease burden of early and late effects

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) P5 - (-)

Poster/Presentation
Number 117

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Arya Shah (Mayo Medical School) PRESENTER	No disclosure on file
E. M. Hoffman, DO, PhD (Mayo Clinic, Neurology)	Dr. Hoffman has nothing to disclose.
Christopher J. Klein, MD, FAAN (Mayo Clinic)	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Faze Medicine .
Nathan P. Staff, MD, PhD, FAAN (Mayo Clinic)	Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.